Penicillin Allergy Evaluation: A Prospective, Multicenter, Open-Label Evaluation of a Comprehensive Penicillin Skin Test Kit
- PMID: 30878711
- DOI: 10.1016/j.jaip.2019.02.040
Penicillin Allergy Evaluation: A Prospective, Multicenter, Open-Label Evaluation of a Comprehensive Penicillin Skin Test Kit
Abstract
Background: Ten percent of the population claims an allergy to penicillin, but 90% of these individuals are not allergic. Patients labeled as penicillin-allergic have higher medical costs, longer hospital stays, are more likely to be treated with broad-spectrum antibiotics, and develop drug-resistant bacterial infections. Most penicillin skin test reagents are not approved by the Food and drug Administration or readily available to evaluate patients labeled penicillin-allergic.
Objective: To determine the negative predictive value (NPV) of the Penicillin Skin Test Kit containing the major allergenic determinant (penicilloyl polylysine), a minor determinant mixture (penicillin G, penicilloate, penilloate), and amoxicillin, produced according to Food and Drug Administration standards.
Methods: This was a prospective, multicenter, open-label investigation of penicillin skin testing using the Penicillin Skin Test Kit. Skin test-negative subjects were challenged with 250 mg amoxicillin, whereas skin test-positive patients were not challenged. The primary end point was NPV of the Penicillin Skin Test Kit, defined as the percentage of subjects with negative skin test results who did not experience an IgE-dependent reaction within 72 hours of amoxicillin challenge.
Results: In total, 455 patients with a history of penicillin allergy underwent skin testing and 63 (13.8%) had 1 or more positive test results; 65% of the positive test results were to the minor determinant mixture and/or amoxicillin alone. In the per protocol group of 373 skin test-negative subjects, 8 developed potential IgE-dependent reactions following oral amoxicillin challenge, translating to an NPV of 97.9% (95% CI, 95.8-99.1; P < .0001). All but 1 of the reactions was mild or moderate, and most subjects who required treatment received only antihistamines.
Conclusions: The Penicillin Skin Test Kit, containing all relevant penicillin allergenic determinants, demonstrated very high NPV. Removal of a penicillin allergy label in a large majority of currently mislabeled patients has substantial personal and public health implications.
Keywords: Allergy; Amoxicillin; Penicillin; Penicilloate; Penicilloyl polylysine; Penilloate; Skin testing.
Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Comment in
-
Once You Label Me….J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):1886-1887. doi: 10.1016/j.jaip.2019.04.041. J Allergy Clin Immunol Pract. 2019. PMID: 31279467 No abstract available.
Similar articles
-
Skin testing with penicilloate and penilloate prepared by an improved method: amoxicillin oral challenge in patients with negative skin test responses to penicillin reagents.J Allergy Clin Immunol. 1997 Nov;100(5):586-91. doi: 10.1016/s0091-6749(97)70159-3. J Allergy Clin Immunol. 1997. PMID: 9389285
-
Utility of minor determinants for skin testing in inpatient penicillin allergy evaluation.Ann Allergy Asthma Immunol. 2017 Sep;119(3):258-261. doi: 10.1016/j.anai.2017.06.009. Epub 2017 Jul 23. Ann Allergy Asthma Immunol. 2017. PMID: 28743423
-
Prospective, multicenter clinical trial to validate new products for skin tests in the diagnosis of allergy to penicillin.J Investig Allergol Clin Immunol. 2013;23(6):398-408. J Investig Allergol Clin Immunol. 2013. PMID: 24459816 Clinical Trial.
-
Penicillin minor determinants: History and relevance for current diagnosis.Ann Allergy Asthma Immunol. 2018 Nov;121(5):537-544. doi: 10.1016/j.anai.2018.09.459. Epub 2018 Sep 21. Ann Allergy Asthma Immunol. 2018. PMID: 30248407 Review.
-
Evaluation and Management of Penicillin Allergy: A Review.JAMA. 2019 Jan 15;321(2):188-199. doi: 10.1001/jama.2018.19283. JAMA. 2019. PMID: 30644987 Review.
Cited by
-
Penicillin Allergy Delabeling: A Multidisciplinary Opportunity.J Allergy Clin Immunol Pract. 2020 Oct;8(9):2858-2868.e16. doi: 10.1016/j.jaip.2020.04.059. J Allergy Clin Immunol Pract. 2020. PMID: 33039010 Free PMC article. Review.
-
The drug allergy history tool (DAHT): Validation of a patient-reported survey instrument.J Allergy Clin Immunol. 2025 Mar 4:S0091-6749(25)00257-X. doi: 10.1016/j.jaci.2025.02.027. Online ahead of print. J Allergy Clin Immunol. 2025. PMID: 40049420
-
Improving routine prenatal penicillin allergy testing for reported penicillin allergy.BMJ Open Qual. 2022 Jul;11(3):e001859. doi: 10.1136/bmjoq-2022-001859. BMJ Open Qual. 2022. PMID: 35906008 Free PMC article.
-
Penicillin allergy delabeling: Opportunities for implementation and dissemination.Ann Allergy Asthma Immunol. 2023 May;130(5):554-564. doi: 10.1016/j.anai.2022.12.023. Epub 2022 Dec 20. Ann Allergy Asthma Immunol. 2023. PMID: 36563744 Free PMC article. Review.
-
Tools for Etiologic Diagnosis of Drug-Induced Allergic Conditions.Int J Mol Sci. 2023 Aug 8;24(16):12577. doi: 10.3390/ijms241612577. Int J Mol Sci. 2023. PMID: 37628756 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical